Whitehead Warren

CIK 00017614491 companyTORONTO, A6

SEC Profile

Transactions

Companies

Filings

CIK

0001761449

Recent Transactions

30 trades

Award
Aptose Biosciences Inc.$APTOF
Director Stock Options (Right to Buy)
2024-02-05+3,333→ 3,333 total
Award
Aptose Biosciences Inc.$APTOF
Director Option Grant
2023-01-19+100,000→ 100,000 total
Award
Aptose Biosciences Inc.$APTOF
Director Option Grant
2022-01-18+50,000→ 50,000 total
Sale
Aptose Biosciences Inc.$APTOF
Common Shares
2021-06-22$3.24/sh−9,600→ 15,000 total
Sale
Aptose Biosciences Inc.$APTOF
Common Shares
2021-06-21$3.35/sh−15,400→ 24,600 total
Award
Aptose Biosciences Inc.$APTOF
Director Stock Option (Right to Buy)
2021-01-04+50,000→ 50,000 total
Exercise/Conversion
Aptose Biosciences Inc.$APTOF
Common Shares
2020-12-22$2.01/sh+20,000→ 60,000 total
Sale
Aptose Biosciences Inc.$APTOF
Common Shares
2020-12-22$4.11/sh−10,000→ 40,000 total
Exercise/Conversion
Aptose Biosciences Inc.$APTOF
Director Stock Option (Right to Buy)
2020-12-22−20,000→ 20,000 total
Sale
Aptose Biosciences Inc.$APTOF
Common Shares
2020-12-22$4.01/sh−10,000→ 50,000 total
Exercise/Conversion
Aptose Biosciences Inc.$APTOF
Director Stock Option (Right to Buy)
2020-06-24+7,000→ 53,000 total
Exercise/Conversion
Aptose Biosciences Inc.$APTOF
Common Shares
2020-06-24$2.60/sh+7,000→ 57,000 total
Sale
Aptose Biosciences Inc.$APTOF
Common Shares
2020-06-24$6.73/sh−12,000→ 45,000 total
Sale
Aptose Biosciences Inc.$APTOF
Common Shares
2020-06-24$6.78/sh−5,000→ 40,000 total
Exercise/Conversion
Aptose Biosciences Inc.$APTOF
Common Shares
2020-06-24$1.02/sh+5,000→ 50,000 total
Exercise/Conversion
Aptose Biosciences Inc.$APTOF
Director Stock Option (Right to Buy)
2020-06-24+5,000→ 0 total
Exercise/Conversion
Aptose Biosciences Inc.$APTOF
Director Stock Option (Right to Buy)
2020-06-23+500→ 0 total
Exercise/Conversion
Aptose Biosciences Inc.$APTOF
Common Shares
2020-06-23$1.60/sh+500→ 51,750 total
Exercise/Conversion
Aptose Biosciences Inc.$APTOF
Common Shares
2020-06-23$1.12/sh+10,000→ 63,000 total
Exercise/Conversion
Aptose Biosciences Inc.$APTOF
Director Stock Option (Right to Buy)
2020-06-23+1,250→ 0 total
Exercise/Conversion
Aptose Biosciences Inc.$APTOF
Director Stock Option (Right to Buy)
2020-06-23+10,000→ 0 total
Exercise/Conversion
Aptose Biosciences Inc.$APTOF
Director Stock Option (Right to Buy)
2020-06-23+1,250→ 0 total
Exercise/Conversion
Aptose Biosciences Inc.$APTOF
Common Shares
2020-06-23$1.91/sh+1,250→ 51,250 total
Exercise/Conversion
Aptose Biosciences Inc.$APTOF
Common Shares
2020-06-23$4.22/sh+1,250→ 53,000 total
Sale
Aptose Biosciences Inc.$APTOF
Common Shares
2020-06-23$7.08/sh−13,000→ 50,000 total
Sale
Aptose Biosciences Inc.$APTOF
Common Shares
2020-06-23$7.17/sh−5,000→ 45,000 total
Award
Aptose Biosciences Inc.$APTOF
Director Option Grant
2020-03-11+50,000→ 50,000 total
Award
Aptose Biosciences Inc.$APTOF
Director Option Grant
2020-03-11+50,000→ 50,000 total
Award
Aptose Biosciences Inc.$APTOF
Director Option Grant
2020-01-31+152,500→ 152,500 total
Award
Aptose Biosciences Inc.$APTOF
Stock Options (Right to Buy)
2019-01-02+40,000→ 40,000 total

Companies

Aptose Biosciences Inc.
Director
$APTOF

Recent Filings

Address

C/O APTOSE BIOSCIENCES INC. 251 CONSUMERS ROAD, SUITE 1105

TORONTO, A6, M2J 4R3

View on SEC.gov